TipRanks
Go Ultimate55% OFF

Curative Biosciences (CBDX) Financial Statements

Curative Biosciences Financial Overview

Curative Biosciences's market cap is currently $25.79K. The company's EPS TTM is ―; its P/E ratio is -0.03; Curative Biosciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Jun 17
Income Statement
Total Revenue$ 0.00
Gross Profit$ -2.85K
Operating Income$ -53.20K
EBITDA$ -50.35K
Net Income$ -53.20K
Balance Sheet
Cash & Short-Term Investments$ 0.00
Total Assets$ 2.27K
Total Debt$ 62.83K
Net Debt$ 62.83K
Total Liabilities$ 633.07K
Stockholders' Equity$ -630.80K
Cash Flow
Free Cash Flow$ -12.80K
Operating Cash Flow$ -12.80K
Investing Cash Flow$ 0.00
Financing Cash Flow$ 12.80K

Currency in USD

Curative Biosciences Earnings and Revenue History

-60K-40K-20K00 %0.4 %0.8 %1.2 %EarningsProfit Margin2017RevenueEarningsProfit Margin

Curative Biosciences Debt to Assets

0250K500K750K27948 %27949 %27950 %27951 %LiabilitiesDebt to Assets2017AssetsLiabilitiesDebt to Assets

Curative Biosciences Cash Flow

-15K-10K-5K05K10K15K2017OperatingInvestingFinancing

Curative Biosciences Forecast EPS vs Actual EPS